US 11312786
Oncofetal antigen binding proteins and related compositions and methods
granted A61KA61K2039/505A61K2039/5152
Quick answer
US patent 11312786 (Oncofetal antigen binding proteins and related compositions and methods) held by Aptevo Research and Development LLC expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aptevo Research and Development LLC
- Grant date
- Tue Apr 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505, A61K2039/5152, A61K38/00, A61K39/395